Innovative Medicine Initiatives – Horizon 2020 Open Calls
16/02/2017
news@umfiasi.ro (544 articole)
0 comentarii
Distribuie

Innovative Medicine Initiatives – Horizon 2020 Open Calls

IMI2-2016-10-01: Understanding hypoglycaemia: the underlying mechanisms and addressing clinical determinants as well as consequences for people with diabetes by combining databases from clinical trials

Status: Open

Publication date: 21 December 2016

Types of action: IMI2-RIA Research and Innovation action

DeadlineModel: two-stage

Opening date: 04 January 2017

Deadline: 28 March 2017 17:00:00 (Brussels time)

2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)

IMI2-2016-10-02: How Big Data could support better diagnosis and treatment outcomes for Prostate Cancer

Status: Open

Publication date: 21 December 2016

Types of action: IMI2-RIA Research and Innovation action

DeadlineModel: two-stage

Opening date: 04 January 2017

Deadline: 28 March 2017 17:00:00 (Brussels time)

2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)

IMI2-2016-10-03: Improving the care of patients suffering from acute or chronic pain

Status: Open

Publication date: 21 December 2016

Types of action: IMI2-RIA Research and Innovation action

DeadlineModel: two-stage

Opening date: 04 January 2017

Deadline: 28 March 2017 17:00:00 (Brussels time)

2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)Web: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/imi2-2016-10-03.html

IMI2-2016-10-04: Creation of a pan-European Paediatric Clinical Trials Network

Status: Open

Publication date: 21 December 2016

Types of action: IMI2-RIA Research and Innovation action

DeadlineModel: two-stage

Opening date: 04 January 2017

Deadline: 28 March 2017 17:00:00 (Brussels time)

2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)

IMI2-2016-10-05: Biomanufacturing 2020: Development of Innovative high throughput analytical tools and methods to characterize cell culture fluid during development and commercial cell culture processes

Status: Open

Publication date: 21 December 2016

Types of action: IMI2-RIA Research and Innovation action

DeadlineModel: two-stage

Opening date: 04 January 2017

Deadline: 28 March 2017 17:00:00 (Brussels time)

2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)

IMI2-2016-10-06: Unlocking the Solute Carrier Gene-Family for Effective New Therapies (Unlock SLCs)

Status: Open

Publication date: 21 December 2016

Types of action: IMI2-RIA Research and Innovation action

DeadlineModel: two-stage

Opening date: 04 January 2017

Deadline: 28 March 2017 17:00:00 (Brussels time)

2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)

IMI2-2016-10-07: Patient perspectives in medicines lifecycle

Status: Open

Publication date: 21 December 2016

Types of action: IMI2-RIA Research and Innovation action

DeadlineModel: two-stage

Opening date: 04 January 2017

Deadline: 28 March 2017 17:00:00 (Brussels time)

2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)

IMI2-2016-10-08: Personalised medicine approaches in autism spectrum disorders

Status: Open

Publication date: 21 December 2016

Types of action: IMI2-RIA Research and Innovation action

DeadlineModel: two-stage

Opening date: 04 January 2017

Deadline: 28 March 2017 17:00:00 (Brussels time)

2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)

 

 

Taguri apel, cercetare
news@umfiasi.ro

news@umfiasi.ro

News@umfiasi.ro este portalul de știri al Universității de Medicină și Farmacie “Grigore T. Popa” Iași.

Comentarii

Nu exista comentarii Fii primul care comenteaza acest articol!

Scrie un comentariu